IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kynam Capital Management, LP

Q4 2023 Holdings

Filed 2024-02-14 | 24 holdings | $902.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Natera Inc(NTRA)COM632307104$150.3M2,400,00016.7%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$122.3M5,660,00013.6%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$119.2M3,005,90413.2%
Vaxcyte Inc(PCVX)COM92243G108$63.0M1,002,4077.0%
Vera Therapeutics Inc(VERA)CL A92337R101$56.1M3,650,3396.2%
Protagonist Therapeutics Inc(PTGX)COM74366E102$46.0M2,004,8755.1%
Immunogen Inc(IMGNEUR)COM45253H101$42.2M1,422,5034.7%
Morphosys AGSPONSORED ADS617760202$41.9M4,234,6854.6%
Cogent Biosciences Inc(COGT)COM19240Q201$34.4M5,854,7663.8%
Liquidia Corporation(LQDA)COM NEW53635D202$32.5M2,698,3243.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$27.6M4,600,0003.1%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$25.4M5,953,8252.8%
Dynavax Technologies Corp(DVAX)COM NEW268158201$21.2M1,514,3832.3%
Wave Life Sciences LTD(WVE)SHSY95308105$19.9M3,932,0822.2%
Corcept Therapeutics Inc(CORT)PutCOM218352102$19.0M585,9002.1%
Travere Therapeutics Inc(TVTX)COM89422G107$18.0M2,000,0002.0%
Viridian Therapeutics Inc(VRDN)COM92790C104$13.2M607,9151.5%
Amarin Corp PLCSPONS ADR NEW023111206$10.5M12,022,9571.2%
Acelyrin IncCOM00445A100$9.0M1,200,0001.0%
Sutro Biopharma IncCOM869367102$8.6M2,001,7271.0%
Burning Rock Biotech LTDSPONSORED ADS12233L107$8.1M8,694,4260.9%
Caribou Biosciences Inc(CRBU)COM142038108$6.1M1,068,5270.7%
Tyra Biosciences Inc(TYRA)COM90240B106$4.7M340,1900.5%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$3.5M442,7040.4%